Raf Roelands

Investment Analyst

Raf joined Korys in 2017. Prior to this he was part of the sales and marketing team of Eurogentec, now a part of the Kaneka corporation. He was subsequently active as a Business Development Manager at Apitope, helping the company finance their drug development and out-license its compounds. Raf holds a MSc in Biochemistry and Biotechnology from the Catholic University Leuven and an MBA from Vlerick Business School. He likes to unwind by spending time with his wife, enjoys traveling the African continent and is a climbing enthusiast.